Associate Director, Clinical Study Management

Millbrae, California, United States

Apply with AI Apply

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceutical, Biotechnology, Pharmaceuticals, Drug DiscoveryIndustries

Requirements

Candidates must possess a minimum of 10 years of related experience with a Bachelor's degree, or 8 years with a post-graduate degree. Experience leading large, global clinical trials, preferably in oncology, is essential, along with in-depth knowledge of ICH-GCP guidelines. A minimum of 3 days per week onsite presence in California or New Jersey offices is required.

Responsibilities

The Associate Director will oversee the execution of clinical trials in oncology and other therapeutic areas, ensuring successful completion within timelines and budget with a focus on quality. This involves leading clinical trial deliverables, timelines, and budgets, working collaboratively with cross-functional teams, and providing direction to study teams. Responsibilities include ensuring compliance with protocols and regulations, overseeing risk management, preparing study timelines, managing vendor relationships, providing progress updates to stakeholders, ensuring proper documentation, and hiring, managing, and mentoring clinical study management personnel.

Skills

Clinical Trial Management

Oncology

Clinical Operations

Budget Management

Timeline Management

Cross-functional Collaboration

Operational Excellence

Eikon Therapeutics

Biotech startup developing innovative medicines

About Eikon Therapeutics

Eikon Therapeutics focuses on discovering and developing new medicines in the pharmaceutical industry. The company employs advanced technologies to study biological systems, aiming to identify new drug targets by examining the dynamic aspects of biology rather than just static chemical processes. Their team consists of diverse professionals, including data scientists, chemists, and engineers, which allows them to combine science and engineering to create new therapies that aim to improve and extend life. A key feature of Eikon's approach is their proprietary single-molecule tracking (SMT) platform, which enables rapid visualization of protein movements in living cells. This technology, along with artificial intelligence and automation, allows for precise inventorying of molecular interactions. Eikon Therapeutics targets patients with serious diseases who need effective treatments, generating revenue through the development and commercialization of their therapies.

Hayward, CaliforniaHeadquarters

2019Year Founded

$750.8MTotal Funding

SERIES_CCompany Stage

AI & Machine Learning, BiotechnologyIndustries

201-500Employees

Benefits

401(k) Company Match

Medical (premiums covered by Eikon at 95%)

Dental Insurance

Vision Insurance

Mental Health Support

Unlimited Paid Time Off

Paid Holidays

Life Insurance

Enhanced Parental Leave

Daily subsidized lunch program

Risks

Competition from biotech unicorns like Abogen Biosciences is increasing.

Integrating new clinical-stage assets may delay drug development timelines.

Reliance on SMT technology risks obsolescence from emerging molecular biology technologies.

Differentiation

Eikon uses proprietary single-molecule tracking for real-time protein movement analysis.

The company integrates AI and automation for large-scale molecular interaction studies.

Eikon's diverse team combines expertise in science, engineering, and technology.

Upsides

Growing interest in SMT technology boosts Eikon's drug discovery potential.

Partnerships with AI firms enhance Eikon's drug candidate identification.

Rising demand for precision medicine aligns with Eikon's focus on dynamic biology.

Land your dream remote job 3x faster with AI

Try Jobo Free